Display options
Cite
Xie Y, Woolbright BL, Kos M, et al. Lack of Direct Cytotoxicity of Extracellular ATP against Hepatocytes: Role in the Mechanism of Acetaminophen Hepatotoxicity. J Clin Transl Res. 2015;1(2):100-106doi: 10.18053/jctres.201502.004.
Xie, Y., Woolbright, B. L., Kos, M., McGill, M. R., Dorko, K., Kumer, S. C., Schmitt, T. M., & Jaeschke, H. (2015). Lack of Direct Cytotoxicity of Extracellular ATP against Hepatocytes: Role in the Mechanism of Acetaminophen Hepatotoxicity. Journal of clinical and translational research, 1(2), 100-106. https://doi.org/10.18053/jctres.201502.004
Xie, Yuchao, et al. "Lack of Direct Cytotoxicity of Extracellular ATP against Hepatocytes: Role in the Mechanism of Acetaminophen Hepatotoxicity." Journal of clinical and translational research vol. 1,2 (2015): 100-106. doi: https://doi.org/10.18053/jctres.201502.004
Xie Y, Woolbright BL, Kos M, McGill MR, Dorko K, Kumer SC, Schmitt TM, Jaeschke H. Lack of Direct Cytotoxicity of Extracellular ATP against Hepatocytes: Role in the Mechanism of Acetaminophen Hepatotoxicity. J Clin Transl Res. 2015;1(2):100-106. doi: 10.18053/jctres.201502.004. Epub 2015 Sep 30. PMID: 26722668; PMCID: PMC4694640.
Copy Download .nbib Format: NLM
Share it on

J Clin Transl Res. 2015;1(2):100-106. doi: 10.18053/jctres.201502.004. Epub 2015 Sep 30.

Lack of Direct Cytotoxicity of Extracellular ATP against Hepatocytes: Role in the Mechanism of Acetaminophen Hepatotoxicity.

Journal of clinical and translational research

Yuchao Xie, Benjamin L Woolbright, Milan Kos, Mitchell R McGill, Kenneth Dorko, Sean C Kumer, Timothy M Schmitt, Hartmut Jaeschke

Affiliations

  1. Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS 66160, USA.
  2. Department of Experimental Surgery, Academic Medical Center, University of Amsterdam, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  3. Department of Surgery, University of Kansas Medical Center, Kansas City, KS 66160, USA.

PMID: 26722668 PMCID: PMC4694640 DOI: 10.18053/jctres.201502.004

Abstract

BACKGROUND: Acetaminophen (APAP) hepatotoxicity is a major cause of acute liver failure in many countries. Mechanistic studies in mice and humans have implicated formation of a reactive metabolite, mitochondrial dysfunction and oxidant stress as critical events in the pathophysiology of APAP-induced liver cell death. It was recently suggested that ATP released from necrotic cells can directly cause cell death in mouse hepatocytes and in a hepatoma cell line (HepG2).

AIM: To assess if ATP can directly cause cell toxicity in hepatocytes and evaluate their relevance in the human system.

METHODS: Primary mouse hepatocytes, human HepG2 cells, the metabolically competent human HepaRG cell line and freshly isolated primary human hepatocytes were exposed to 10-100 μM ATP or ATγP in the presence or absence of 5-10 mM APAP for 9-24 h.

RESULTS: ATP or ATγP was unable to directly cause cell toxicity in all 4 types of hepatocytes. In addition, ATP did not enhance APAP-induced cell death observed in primary mouse or human hepatocytes, or in HepaRG cells as measured by LDH release and by propidium iodide staining in primary mouse hepatocytes. Furthermore, addition of ATP did not cause mitochondrial dysfunction or enhance APAP-induced mitochondrial dysfunction in primary murine hepatocytes, although ATP did cause cell death in murine RAW macrophages.

CONCLUSIONS: It is unlikely that ATP released from necrotic cells can significantly affect cell death in human or mouse liver during APAP hepatotoxicity.

RELEVANCE FOR PATIENTS: Understanding the mechanisms of APAP-induced cell injury is critical for identifying novel therapeutic targets to prevent liver injury and acute liver failure in APAP overdose patients.

Keywords: Acetaminophen hepatotoxicity; damage-associated molecular patterns; human hepatocytes; necrosis; sterile inflammation

References

  1. Toxicol Appl Pharmacol. 2014 Sep 15;279(3):266-74 - PubMed
  2. J Photochem Photobiol B. 2010 Mar 8;98(3):216-22 - PubMed
  3. Chem Biol Interact. 2007 May 20;168(1):66-73 - PubMed
  4. Liver Int. 2010 Oct;30(9):1280-92 - PubMed
  5. J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:173-9 - PubMed
  6. FEBS Lett. 2007 Jul 10;581(17):3260-6 - PubMed
  7. Toxicol Appl Pharmacol. 2010 Sep 15;247(3):169-78 - PubMed
  8. Free Radic Res. 2003 Dec;37(12):1289-97 - PubMed
  9. Trends Pharmacol Sci. 2012 Apr;33(4):200-6 - PubMed
  10. Expert Opin Drug Metab Toxicol. 2014 Jul;10 (7):1005-17 - PubMed
  11. Toxicol Appl Pharmacol. 2006 Oct 1;216(1):98-107 - PubMed
  12. Hepatology. 2008 Feb;47(2):698-705 - PubMed
  13. Toxicol Sci. 2013 Jan;131(1):325-35 - PubMed
  14. Drug Metab Dispos. 2003 Aug;31(8):1035-42 - PubMed
  15. Clin Liver Dis. 2007 Aug;11(3):525-48, vi - PubMed
  16. Toxicol Appl Pharmacol. 2014 Mar 1;275(2):122-33 - PubMed
  17. Biochem Biophys Res Commun. 2012 Mar 30;420(1):102-7 - PubMed
  18. Cell Commun Signal. 2013 Feb 05;11(1):10 - PubMed
  19. Am J Physiol Gastrointest Liver Physiol. 2003 Jan;284(1):G15-26 - PubMed
  20. Toxicol Sci. 2004 Aug;80(2):343-9 - PubMed
  21. Hepatology. 2011 Mar;53(3):974-82 - PubMed
  22. Hepatology. 2014 Oct;60(4):1336-45 - PubMed
  23. J Gastroenterol Hepatol. 2013 Mar;28(3):394-400 - PubMed
  24. Hepatology. 2002 Feb;35(2):289-98 - PubMed
  25. J Hepatol. 2012 May;56(5):1070-9 - PubMed
  26. Liver Int. 2012 Jan;32(1):8-20 - PubMed
  27. Toxicol Appl Pharmacol. 1997 Mar;143(1):1-12 - PubMed
  28. Toxicol Lett. 2010 Feb 15;192(3):387-94 - PubMed
  29. Drug Metab Rev. 2012 Feb;44(1):88-106 - PubMed
  30. Nat Protoc. 2006;1(3):1112-6 - PubMed
  31. J Clin Invest. 2012 Apr;122(4):1574-83 - PubMed
  32. Toxicol Appl Pharmacol. 2011 May 1;252(3):289-97 - PubMed
  33. Am J Physiol Gastrointest Liver Physiol. 2012 May 15;302(10 ):G1171-9 - PubMed
  34. Semin Liver Dis. 1990 Nov;10 (4):267-78 - PubMed

Publication Types

Grant support